| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |